NephroPlus IPO: Dialysis Giant Plans Global Leap

NephroPlus, a leading dialysis specialist in India and Asia, is preparing for an initial public offering (IPO) to fuel its expansion strategy. The company plans to utilize the IPO funds for capital expenditures, debt reduction, and general corporate purposes, aiming to achieve a debt-free status. This financial strengthening is expected to support its ambitious plans for both domestic and international growth.

The dialysis network currently operates 519 clinics across 350 cities in five countries, with international operations already contributing approximately 40% of its revenue. NephroPlus is focused on scaling its presence in existing markets like the Philippines and Uzbekistan, while also preparing for a launch in Saudi Arabia. This global outlook is a key driver for its upcoming public offering.

With a significant monthly volume of dialysis treatments, NephroPlus leverages scale to maintain cost efficiency and profitability. The company has demonstrated a strengthening financial performance, with strong EBITDA and ROCE margins across its various business models. NephroPlus remains committed to focusing solely on dialysis, recognizing the vast addressable market both in India and globally.